Kazia Therapeutics Ltd ADR (KZIA) — Cash Flow Reinvestment Rate
Latest as of September 2021:
1.00x
Kazia Therapeutics Ltd ADR (KZIA) has a Cash Flow Reinvestment Rate of 1.00x as of September 2021, reinvesting $3.16 Million (capex $1.58 Million plus investments $-1.58 Million) from operating cash flow of $3.16 Million. Check earnings quality score of Kazia Therapeutics Ltd ADR to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
1.00x
(Capex + Investments) / Operating CF
Total Reinvested
$3.16 Million
Capex + Investments
Operating Cash Flow
$3.16 Million
USD
Capital Expenditures
$1.58 Million
USD
Annual Cash Flow Reinvestment Rate for Kazia Therapeutics Ltd ADR (None–None)
Year-by-year capital reinvestment analysis for Kazia Therapeutics Ltd ADR. For live market cap and broader valuation context, see Kazia Therapeutics Ltd ADR market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow